Jiangxi Institute of Biological Products Inc. (SEHK: 6915)
Health Care · Biotechnology · CN
HK$5.25
-7.00% today · -46.3% 1Y
Public summary
A free snapshot of Jiangxi Institute of Biological Products Inc., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app Jiangxi Institute of Biological Products Inc. (SEHK: 6915) operates in the Biotechnology industry within the Health Care sector. The company is valued at $206.36M.
Over the last twelve months the share price has lost 46.3%, trading between 3.95 and 21.10.
Tweenvest scores Jiangxi Institute of Biological Products Inc. across four factors: quality 92/100, value 64/100. Its strongest factor is quality.
6915 price history
Key figures
- Market cap
- $206.36M
- Revenue (TTM)
- $32.24M
- P/E
- 17.30
- EPS
- 0.39
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- HK$21.10
- 52-week low
- HK$3.95
- Avg volume (3M)
- —
- Shares outstanding
- 308.38M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| HST Global, Inc.OTCPK: HSTC | $209.33M | $0.70 | +423.56% |
| AC Immune SANasdaqGM: ACIU | $208.80M | $2.10 | -0.47% |
| Transgene SAENXTPA: TNG | $208.02M | €0.69 | -0.86% |
| Jiangsu Gdk Biological Technology Co., LtdSHSE: 688670 | $207.05M | CN¥11.21 | -5.00% |
| TCM Biotech International Corp.TWSE: 4169 | $205.35M | NT$102.00 | -4.67% |
| Guangzhou Innogen Pharmaceutical Group Co., LtdSEHK: 2591 | $204.09M | HK$3.51 | -1.27% |
| Keros Therapeutics, Inc.NasdaqGM: KROS | $202.13M | $10.30 | +2.18% |
| ROKIT Healthcare Inc.KOSDAQ: A376900 | $201.59M | ₩15,500.00 | -1.90% |